1. Drugs and lactation database, Lactmed.
2. Schaefer C , Spielmann H , Vetter K , Weber-Schöndorfer C. Arzneimittel in Schwangerschaft und Stillzeit. 8 ed. Urban & Fischer Verlag/Elsevier GmbH. 2012.
3. Hale TW. Medications and mothers’ milk. 14 ed. Hale Publishing. 2010.
4. Hohlfeld P , Marty F. Surveillance foetale durant la grossesse. In: SAS L , ed. Le livre de l’interne : obstétrique. 2012:1–8.
5. Jonville-Béra AP , Vial T. Médicaments et grossesse : prescrire et évaluer le risque. Elsevier Masson. 2012.
6. Bonduelle M , Oberye J , Mannaerts B , Devroey P. Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation . Hum Reprod. 2010;25:1433–40.
7. Briggs GG , Freeman RK , Yaffe SJ. Drugs in pregnancy and lactation : A reference guide to fetal and neonatal risk. 9th ed. Lippincott Williams & Wilkins (LWW). 2011.
8. Centre de référence sur les agents tératogènes de Paris. [cited ; Available from : www.lecrat.org].
9. Bahn RS , Burch HS , Cooper DS , Garber JR , Greenlee CM , Klein IL , et al. The role of propylthiouracil in the management of graves’ disease in adults: Report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration . Thyroid. 2009;19:673–4.
